Literature DB >> 10476749

Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables.

A W Bossink1, A B Groeneveld, L G Thijs.   

Abstract

Fever suggests the likelihood of severe microbial infection. Abnormal temperature, tachycardia, tachypnea, and abnormal white blood cell counts define the systemic inflammatory response syndrome (SIRS). In 300 hospitalized medical patients with fever, we determined clinical variables and procalcitonin, elastase-alpha1-antitrypsin, and lactoferrin levels in plasma. Of the patients, 71% had clinical infection (by clinical judgment) and 44% had microbial infection (by microbiological testing). SIRS occurred in 95%, and the 28-day mortality rate was 9%. The sensitivity for predicting microbial infection, bacteremia, and mortality was less but the specificity was greater for supranormal procalcitonin, elastase-alpha1-antitrypsin, and lactoferrin levels than for SIRS. The area under the receiver operating characteristic curve (AUC) for microbial infection was higher for procalcitonin and elastase-alpha1-antitrypsin levels than for clinical variables and lactoferrin level. The AUC for bacteremia was also higher for inflammatory factors (>0.70; P < .001) than for clinical variables. The AUC for mortality (P < .05) was 0.79 for the respiratory rate, 0.69 for elastase-alpha1-antitrypsin level, 0.65 for heart rate, 0.61 for procalcitonin level, and 0.60 for white blood cell count. In febrile medical patients, plasma procalcitonin and elastase-alpha1-antitrypsin levels may predict microbial infection and bacteremia better than (and mortality as well as) do clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10476749     DOI: 10.1086/520222

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  23 in total

1.  Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients.

Authors:  Raluca Dumea; Dimitrie Siriopol; Simona Hogas; Irina Mititiuc; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2013-08-30       Impact factor: 2.370

2.  [Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy].

Authors:  M Hochreiter; T Köhler; A-M Schweiger; F S Keck; B Bein; T von Spiegel; S Schröder
Journal:  Anaesthesist       Date:  2008-06       Impact factor: 1.041

3.  Circulating inflammatory mediators in patients with fever: predicting bloodstream infection.

Authors:  A B Groeneveld; A W Bossink; G J van Mierlo; C E Hack
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

Review 4.  Brief report: incidence, etiology, risk factors, and outcome of hospital-acquired fever: a systematic, evidence-based review.

Authors:  Daniel R Kaul; Scott A Flanders; James M Beck; Sanjay Saint
Journal:  J Gen Intern Med       Date:  2006-11       Impact factor: 5.128

5.  Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis.

Authors:  Sacha Zeerleder; Christoph Caliezi; Gerard van Mierlo; Anke Eerenberg-Belmer; Irmela Sulzer; C Erik Hack; Walter A Wuillemin
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

Review 6.  Tryptophanyl-tRNA Synthetase as a Potential Therapeutic Target.

Authors:  Young Ha Ahn; Se-Chan Oh; Shengtao Zhou; Tae-Don Kim
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  Utility of Procalcitonin (PCT) and Mid regional pro-Adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score.

Authors:  Francesco Travaglino; Benedetta De Berardinis; Laura Magrini; Cristina Bongiovanni; Marcello Candelli; Nicolò Gentiloni Silveri; Jacopo Legramante; Alberto Galante; Gerardo Salerno; Patrizia Cardelli; Salvatore Di Somma
Journal:  BMC Infect Dis       Date:  2012-08-08       Impact factor: 3.090

8.  Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome.

Authors:  Pierre Emmanuel Charles; Claire Tinel; Saber Barbar; Serge Aho; Sébastien Prin; Jean Marc Doise; Nils Olivier Olsson; Bernard Blettery; Jean Pierre Quenot
Journal:  Crit Care       Date:  2009-03-16       Impact factor: 9.097

9.  Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial.

Authors:  Marcel Hochreiter; Thomas Köhler; Anna Maria Schweiger; Fritz Sixtus Keck; Berthold Bein; Tilman von Spiegel; Stefan Schroeder
Journal:  Crit Care       Date:  2009-06-03       Impact factor: 9.097

10.  Serum procalcitonine levels as an early diagnostic indicator of sepsis.

Authors:  Anila Beqja-Lika; Anyla Bulo-Kasneci; Etleva Refatllari; Nevila Heta-Alliu; Alma Rucaj-Barbullushi; Iris Mone; Anila Mitre
Journal:  Mater Sociomed       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.